Drug Information for TAZORAC (tazarotene) Gel 0.05%(tazarotene) Gel 0.1% (Allergan, Inc.): INDICATIONS AND USAGE

Ads
  • TAZORAC® (tazarotene) Gel 0.05% and 0.1% are indicated for the topical treatment of patients with stable plaque psoriasis of up to 20% body surface area involvement.

    TAZORAC® (tazarotene) Gel 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity.

    The efficacy of TAZORAC® Gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established.

  • Drug Information Provided by National Library of Medicine (NLM).
Ads